IntellaTip MiFi XP Asymmetric (N4) Curve Temperature Ablation Catheters 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Boston Scientific Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2015-RN-01156-1
  • 사례 위험등급
    Class I
  • 사례 시작날짜
    2015-11-26
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Boston scientific has received reports of bent distal tips, and in four cases, this situation resulted in exposed internal wires in the asymmetric curve models (known as n4) of intellatip mifi xp. the most common clinical observation is prolongation of the procedure to exchange a bent catheter with a new device. though no serious patient harms have been reported, a bent catheter tip or exposed internal wire could result in tissue damage to blood vessels and cardiac structures. this may result in cardiac or vascular perforation, with need for invasive intervention to prevent permanent damage or impairment.
  • 조치
    Boston Scientific are advising users to inspect and quarantine any affected stock and return it to Boston Scientific. This action has been closed-out on 26/08/2016.

Device

  • 모델명 / 제조번호(시리얼번호)
    IntellaTip MiFi XP Asymmetric (N4) Curve Temperature Ablation CathetersMaterial Numbers: M004EPM4500N40, M004EPM4790N40, M004PM4500N40 and M004PM4790N40Multiple Lot Numbers affectedARTG Number: 232994
  • 의료기기 분류등급
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • 제조사 의견
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    DHTGA